Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO).

Juan Manuel Sepúlveda SánchezMiguel Gil-GilMiriam Alonso-GarcíaMaría Ángeles Vaz SalgadoElena VicenteCarlos Mesía BarrosoÁngel Rodríguez SánchezGema DuránRamón De Las PeñasJosé Muñoz-LangaGuillermo VelascoAurelio Hernández-LaínAmaya HilarioMiguel Navarro MartínManuel BenavidesLaura OleagaDiana Cantero MontenegroYolanda RuanoPilar Sánchez-GómezMaría Cruz Martín-SoberónRobert Morales-LlombartVanessa PachónEstela Pineda

Published in: Targeted oncology (2021)

This study is registered with ClinicalTrials.gov, identifier NCT0253032 (retrospectively registered on 21 August 2015).

Keyphrases

palliative care
open label
clinical trial
metastatic breast cancer
study protocol
double blind
placebo controlled